Illumina Inc Revenue Growth Rates (ILMN), Current and Historic Growth - CSIMarket
CSIMarket
 


Illumina Inc   (NASDAQ: ILMN)
 

ILMN's Revenue Growth by Quarter and Year

Illumina Inc 's Revenue results by quarter and year




API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/ILMN/growth
https://api.csimarket.com/api/v1/companies/ILMN/fundamentals
https://api.csimarket.com/api/v1/companies/ILMN/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
ILMN Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 1,129.00
2nd Quarter June 1,159.00
1st Quarter March 1,091.00
FY 3,379.00

ILMNs Annual Revenue
Illumina Inc 's Revenue in the fiscal year 2025 $ 4,343.00 millions
Illumina Inc 's Revenue in the fiscal year 2024 $ 4,372.00 millions
Illumina Inc 's Revenue in the fiscal year 2023 $ 4,504.00 millions
Illumina Inc 's Revenue in the fiscal year 2022 $ 4,584.00 millions
Illumina Inc 's Revenue in the fiscal year 2021 $ 4,526.00 millions




ILMN Revenue third quarter 2026 Y/Y Growth Comment
Illumina Inc reported Revenue growth of 4.15% year on year in the third quarter 2026, to $ 1,129.00 millions, this is lower than Illumina Inc 's recent average Revenue increase of 12.4%.

Looking into third quarter 2026 results within Laboratory Analytical Instruments industry 14 other companies have achieved higher Revenue growth. While Illumina Inc ' s Revenue increase of 4.15% ranks overall at the positon no. 2529 in the third quarter 2026.




ILMN Revenue ( Y/Y Growth %) 2026
FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 4.15 %
2nd Quarter June 9.44 %
1st Quarter March 4.8 %
FY   -

Financial Statements
Illumina Inc 's third quarter 2026 Revenue $ 1,129.00 millions ILMN's Income Statement
Illumina Inc 's third quarter 2025 Revenue $ 1,084.00 millions Quarterly ILMN's Income Statement


ILMN Revenue (Quarter on Quarter Growth %)

2026
FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -2.59 %
2nd Quarter June 6.23 %
1st Quarter March -5.87 %
FY (Year on Year)   -




Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #15
Healthcare Sector #365
Overall #2529

Revenue Y/Y Growth Statistics
High Average Low
83.62 % 12.4 % -8.58 %
(Dec. 30, 2015)   (Jan 03 2021)
Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #15
Healthcare Sector #365
Overall #2529
Revenue Y/Y Growth Statistics
High Average Low
83.62 % 12.4 % -8.58 %
(Dec. 30, 2015)   (Jan 03 2021)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Illumina Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
25.43 % 3.02 % -26.31 %
(Sep 27 2020)  


ILMN's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2026 Illumina Inc disclosed fall in Revenue from the second quarter by -2.59% to $ 1,129.00 millions, from $ 1,159.00 millions achived in the previous reporting period.

Although periodic circumstance commonly energize III. Quarter 2026 Revenue, this plainly could not be substantial to rescue Laboratory Analytical Instruments's company achievement, Most analysts pointed out.

Within Laboratory Analytical Instruments industry 5 other companies have achieved higher Revenue quarter on quarter growth. While Illumina Inc 's Revenue growth quarter on quarter, overall rank is 1005.


Revenue Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #6
Healthcare Sector #149
Overall #1005
Revenue Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #6
Healthcare Sector #149
Overall #1005
Revenue Q/Q Growth Statistics
High Average Low
25.43 % 3.02 % -26.31 %
(Sep 27 2020)  


ILMN's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2026 Illumina Inc disclosed fall in Revenue from the second quarter by -2.59% to $ 1,129.00 millions, from $ 1,159.00 millions achived in the previous reporting period.

Although periodic circumstance commonly energize III. Quarter 2026 Revenue, this plainly could not be substantial to rescue Laboratory Analytical Instruments's company achievement, Most analysts pointed out.

Within Laboratory Analytical Instruments industry 5 other companies have achieved higher Revenue quarter on quarter growth. While Illumina Inc 's Revenue growth quarter on quarter, overall rank is 1005.


Illumina Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 27 2026)
12 Months Ending (Jun 28 2026) 12 Months Ending (Mar 29 2026) 12 Months Ending (Dec 28 2025) 12 Months Ending (Sep 28 2025)
Cumulative Revenue 12 Months Ending $ 4,538.00
Y / Y Revenue Growth (TTM) 5.83 %
Year on Year Revenue Growth Overall Ranking # 2907
Seqeuential Revenue Change (TTM) 1 %
Seq. Revenue Growth (TTM) Overall Ranking # 2746


Cumulative Revenue growth Comment
Although Illumina Inc 's Annual Revenue growth year on year were below company's average 12.13% , Revenue announced in the Sep 27 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 5.83% year on year, from 4.88% in Jun 28 2026.

In the Healthcare sector 406 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 722 to 2907.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 17
Healthcare Sector # 407
Overall # 2907

Revenue TTM Y/Y Growth Statistics
High Average Low
47.56 %
12.13 %
-8.58 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 17
Sector # 388
S&P 500 # 2746
Cumulative Revenue growth Comment
Although Illumina Inc 's Annual Revenue growth year on year were below company's average 12.13% , Revenue announced in the Sep 27 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 5.83% year on year, from 4.88% in Jun 28 2026.

In the Healthcare sector 406 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 722 to 2907.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 17
Healthcare Sector # 407
Overall # 2907

Revenue TTM Y/Y Growth Statistics
High Average Low
47.56 %
12.13 %
-8.58 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 17
Sector # 388
S&P 500 # 2746




Other Revenue Growth
Laboratory Analytical Instruments Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ILMN's Revenue Growth Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue fall for the quarter ending Sep 27 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 27 2026
Addus Homecare Corp7.19%$ 7.193 millions
Pacific Biosciences Of California Inc 7.03%$ 7.026 millions
Bristol myers Squibb Company6.93%$ 6.930 millions
Labcorp Holdings Inc 6.92%$ 6.917 millions
Gilead Sciences Inc 6.83%$ 6.835 millions
Arcturus Therapeutics Holdings Inc 6.68%$ 6.682 millions
National Healthcare Corp6.61%$ 6.614 millions
Tenet Healthcare Corp6.47%$ 6.466 millions
Phibro Animal Health Corporation6.32%$ 6.320 millions
Mettler toledo International Inc 6.27%$ 6.273 millions
Agilon Health Inc 5.86%$ 5.864 millions
Johnson and Johnson5.86%$ 5.860 millions
Stoke Therapeutics Inc 5.86%$ 5.860 millions
Genedx Holdings Corp 5.64%$ 5.642 millions
Adma Biologics Inc 5.59%$ 5.595 millions
Innoviva Inc 5.55%$ 5.551 millions
Universal Health Services Inc 5.30%$ 5.297 millions
Acadia Healthcare Company Inc 5.14%$ 5.136 millions
Lumexa Imaging Holdings Inc 5.03%$ 5.032 millions
Bio techne Corp4.75%$ 4.753 millions
Merck and Co Inc 4.68%$ 4.683 millions
Davita Inc 4.62%$ 4.617 millions
Sotera Health Company4.61%$ 4.613 millions
Avantor Inc 4.59%$ 4.588 millions
Icu Medical Inc4.39%$ 4.388 millions
Illumina Inc 4.15%$ 4.151 millions
Agenus Inc4.14%$ 4.144 millions
United Therapeutics Corporation4.13%$ 4.128 millions
Option Care Health Inc 4.09%$ 4.086 millions
Henry Schein Inc 3.95%$ 3.953 millions


About Illumina Inc Revenue Growth Rates (ILMN), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Illumina Inc (CIK 1110803).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001110803-26-000207
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Illumina Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.